Indeed, both pancreatic cancer cells and tissues highly expressed CXCR4 and ACKR3 receptors on their surface, which are activated by CAFs-released CXCL12 chemokine [70, 71]. This evidence concerns the gene CXCL12 and pancreatic neoplasm.